
Request appointment
12902 Usf Magnolia DrTampa, FL 33612
Overview of Dr. Phuoc
Dr. Vania Phuoc is an internist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from Baylor College of Medicine and has been in practice 12 years. She is one of 208 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Internal Medicine. She has more than 10 publications and over 100 citings.
Education & Training
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2017 - 2020
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2014 - 2017
Baylor College of MedicineClass of 2014
Certifications & Licensure
FL State Medical License 2017 - 2027
MN State Medical License 2015 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2017
- CMS Meaningful Use Stage 1 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2017
Publications & Presentations
PubMed
- Cutaneous Reactions to Iron Infusions: A Case Report and Clinical Review.Neil Patil, Sairekha Ravichandran, Jane Messina, Kedar Kirtane, Vania Phuoc
Ejhaem. 2025-08-01 - 10 citationsPhase II trial of brain MRI surveillance in stage IV breast cancer.Kamran A Ahmed, Youngchul Kim, Avan J Armaghani, John A Arrington, Ricardo L Costa
Neuro-Oncology. 2025-07-30 - 1 citationsBloodless surgery in urologic oncology: A review of hematologic, anesthetic, and surgical considerations.Aaron S Dahmen, Vania H Phuoc, Jonathan B Cohen, Wade J Sexton, Sephalie Y Patel
Urologic Oncology. 2023-04-01
Journal Articles
- Axicabtagene Ciloleucel (KTE-C19), an Anti-CD19 CAR T Therapy for the Treatment of relapsed/refractory Aggressive B-cell Non-Hodgkin’s LymphomaJulio C Chavez, Vania H Phuoc, Therapeutics and Clinical Risk Management
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









